Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillemette Duchateau-Nguyen

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Microbiology|April 4, 2002
Translational readthrough of the PDE2 stop codon modulates cAMP levels in Saccharomyces cerevisiaeOlivier Namy, Guillemette Duchateau-Nguyen, Jean-Pierre Rousset
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|February 24, 2005
A pairwise alignment algorithm which favors clusters of blocksElodie Nédélec, Thomas Moncion, Elisabeth Gassiat, et al.
Frontiers in Pharmacology|May 18, 2026
Analysis of rat toxicology studies: statistical agreement between virtual and concurrent controls in detecting treatment effects on liver enzymesGuillemette Duchateau-Nguyen, Matteo Piraino, Dragomir Ivanov Draganov, et al.
Nucleic Acids Research|April 25, 2003
Identification of stop codon readthrough genes in Saccharomyces cerevisiaeOlivier Namy, Guillemette Duchateau-Nguyen, Isabelle Hatin, et al.
Clinical Kidney Journal|April 1, 2014
Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4Chek Ing Kiu Weber, Guillemette Duchateau-Nguyen, Corinne Solier, et al.
Bioinformatics (Oxford, England)|February 14, 2003
Towards a computational model for -1 eukaryotic frameshifting sitesMichaël Bekaert, Laure Bidou, Alain Denise, et al.
BMC Medical Genomics|June 9, 2009
A longitudinal study of gene expression in healthy individualsChris Karlovich, Guillemette Duchateau-Nguyen, Andrea Johnson, et al.
Molecular Cancer Therapeutics|February 2, 2013
Quantitative chemical proteomics profiling differentiates erlotinib from gefitinib in EGFR wild-type non-small cell lung carcinoma cell linesAngélique Augustin, Jens Lamerz, Hélène Meistermann, et al.
Frontiers in Toxicology|December 19, 2025
Retrospective analysis of clinical laboratory parameters in Han Wistar rat controlsRupert Kellner, Alexander Amberg, Frank Bringezu, et al.
Journal for Immunotherapy of Cancer|November 14, 2025
Identification of conserved immune-related adverse event risk factors and clinical outcomes in a pan-immunotherapy data martDavid F Lamparter, Virginia C Schmid, Rajat Mohindra, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Microbiology|April 4, 2002
Translational readthrough of the PDE2 stop codon modulates cAMP levels in Saccharomyces cerevisiaeOlivier Namy, Guillemette Duchateau-Nguyen, Jean-Pierre Rousset
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|February 24, 2005
A pairwise alignment algorithm which favors clusters of blocksElodie Nédélec, Thomas Moncion, Elisabeth Gassiat, et al.
Frontiers in Pharmacology|May 18, 2026
Analysis of rat toxicology studies: statistical agreement between virtual and concurrent controls in detecting treatment effects on liver enzymesGuillemette Duchateau-Nguyen, Matteo Piraino, Dragomir Ivanov Draganov, et al.
Nucleic Acids Research|April 25, 2003
Identification of stop codon readthrough genes in Saccharomyces cerevisiaeOlivier Namy, Guillemette Duchateau-Nguyen, Isabelle Hatin, et al.
Clinical Kidney Journal|April 1, 2014
Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4Chek Ing Kiu Weber, Guillemette Duchateau-Nguyen, Corinne Solier, et al.
Bioinformatics (Oxford, England)|February 14, 2003
Towards a computational model for -1 eukaryotic frameshifting sitesMichaël Bekaert, Laure Bidou, Alain Denise, et al.
BMC Medical Genomics|June 9, 2009
A longitudinal study of gene expression in healthy individualsChris Karlovich, Guillemette Duchateau-Nguyen, Andrea Johnson, et al.
Molecular Cancer Therapeutics|February 2, 2013
Quantitative chemical proteomics profiling differentiates erlotinib from gefitinib in EGFR wild-type non-small cell lung carcinoma cell linesAngélique Augustin, Jens Lamerz, Hélène Meistermann, et al.
Frontiers in Toxicology|December 19, 2025
Retrospective analysis of clinical laboratory parameters in Han Wistar rat controlsRupert Kellner, Alexander Amberg, Frank Bringezu, et al.
Journal for Immunotherapy of Cancer|November 14, 2025
Identification of conserved immune-related adverse event risk factors and clinical outcomes in a pan-immunotherapy data martDavid F Lamparter, Virginia C Schmid, Rajat Mohindra, et al.
Pageof 2